Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA - Test2 - elhamkhani - TriplyDB

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA

http://www.wikidata.org/entity/Q24564700

about

P1343

Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation Intracellular retention, degradation, and signaling of glycosylation-deficient FGFR2 and craniosynostosis syndrome-associated FGFR2C278F cDNA cloning and inducible expression of human multidrug resistance associated protein 3 (MRP3)Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues MRP3, an organic anion transporter able to transport anti-cancer drugs Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs ABC transporters in fish species: a review Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane pABC11 (also known as MOAT-C and MRP5), a member of the ABC family of proteins, has anion transporter activity but does not confer multidrug resistance when overexpressed in human embryonic kidney 293 cells Inhibitory effect of the reversal agents V-104, GF120918 and Pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport Role of multidrug resistance protein 2 (MRP2) in glutathione-bimane efflux from Caco-2 and rat renal proximal tubule cells Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion Characterization of the 5'-flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) gene Multidrug resistance associated protein 2 mediates transport of prostaglandin E2 Sox2 induction by FGF and FGFR2 activating mutations inhibits Wnt signaling and osteoblast differentiation High-dose retinoic acid modulates rat calvarial osteoblast biology.Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts.Involvement of the multidrug resistance protein 3 in drug sensitivity and its expression in human glioma.Small-molecule multidrug resistance-associated protein 1 inhibitor reversan increases the therapeutic index of chemotherapy in mouse models of neuroblastoma.Interaction of gatifloxacin with efflux transporters: a possible mechanism for drug resistance Usefulness of the MRP2 promoter to overcome the chemoresistance of gastrointestinal and liver tumors by enhancing the expression of the drug transporter OATP1B1 ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2.Mycophenolic acid glucuronide is transported by multidrug resistance-associated protein 2 and this transport is not inhibited by cyclosporine, tacrolimus or sirolimus Cranial sutures as intramembranous bone growth sites.Osseous tissue engineering in oncologic surgery.Differences in the expression of endogenous efflux transporters in MDR1-transfected versus wildtype cell lines affect P-glycoprotein mediated drug transport.Mechanisms and clinical implications of renal drug excretion.Role of N-cadherin in bone formation.Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma.Sensitization of cells overexpressing multidrug-resistant proteins by pluronic P85.The role of drug efflux pumps in acute myeloid leukemia.Using Drosophila melanogaster to uncover human disease gene function and potential drug target proteins.Shiga-like toxin II impairs hepatobiliary transport of doxorubicin in rats by down-regulation of hepatic P glycoprotein and multidrug resistance-associated protein Mrp2 Active transport of the angiotensin-II antagonist losartan and its main metabolite EXP 3174 across MDCK-MDR1 and caco-2 cell monolayers.Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor Photoaffinity labeling of the multidrug resistance protein 2 (ABCC2/cMOAT) with a photoreactive analog of LTC(4)The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs Differential effect of P-gp and MRP2 on cellular translocation of gemifloxacin Cytokine therapy for craniosynostosis.Practical aspects of transporter model systems: a case study involving SQV.

P2860

Q54904784-083C2DC7-219D-4767-B44A-999FBB234217

P1343

Q24296414-5C91D7AE-FDBF-4892-BAA9-A8D4740D1298 Q24297195-ACC0F8A2-D2C9-431E-BC0F-8F1F082EA5DF Q24314274-30D49613-3C46-46AB-A6E1-2AD3CC4B5996 Q24533593-FC5BF160-2EA1-429D-AADC-DE6F5114ABF0 Q24650550-33851552-C444-4DDE-9C97-7B0E43459898 Q24681283-A83B47CC-1B9B-4A19-92E3-D5EFB1B6F387 Q26823286-7C4A3F7B-8C24-44B8-A4A3-7665F0C3F595 Q28139968-E88239B5-C3C0-47C2-9AF3-4BEA268366BF Q28141486-AE1C3EB9-7D9A-488C-B77E-B69C2EB2A623 Q28344522-964B373A-2024-48E7-8EA2-CA8698E33456 Q28362690-397D2CB0-2283-4E8A-950F-222AA9A49101 Q28366592-AAB01F93-B0C5-4B8A-88CE-806D4C585A4A Q28371752-2D97A645-7D28-47E2-B5B0-0DA06AF7D66A Q28580790-F8F94B46-D672-4784-BEC8-A547C1C38840 Q28593870-79770402-BC85-4634-BE1F-7589539C3745 Q29465464-D5ED1132-1EA0-40FA-A850-8238F13D4670 Q31948333-EB6A1954-0371-493F-BA41-6A9FE42B0526 Q32063211-BBAE3978-BD45-414F-802C-166D0F3234E6 Q33490314-5E4C6861-FC31-47E7-B858-CEFA12CABC15 Q33614494-10B6A01F-94DA-441D-82AA-09564452B81D Q33798494-26D4FE6D-1E96-4E25-B7E0-B99770675954 Q33938893-555BA59E-44B8-4AA0-A898-8DB3C3DD72E2 Q33977234-21E387C8-1A72-4B20-91BB-4D2C91573FC0 Q34085716-0C2BBA95-87CA-4B24-B37D-F47EAA97B246 Q34117037-639E75B8-BBEB-4B33-8E7F-FEE977F5A520 Q34124847-B1223DC0-C006-4827-8901-75F716218907 Q34479011-BA060281-C88F-4F2C-A73F-1B3FA9549998 Q34539995-43CFA009-1CBA-40F3-A792-EE8C88D2A17C Q34627891-E1E6C04A-43DC-420A-B3EC-B35658C8C3AA Q34761824-AA446FD2-C07B-40BF-A0AB-099987F50018 Q34769834-EB8E757A-8A34-4611-B130-072BA7CE81E9 Q34837480-86D4F3AD-0475-4793-9845-A21983BC0535 Q34938668-A21E7340-A8D7-402C-9D8E-5C6D173BC6FE Q35042006-E40722A0-85AC-4A63-9407-1F0BAA82B231 Q35196297-2B08E6E0-48A5-4597-9397-73687F96AABA Q35232228-30D0D006-BEA6-4CD8-A884-49775710F9C9 Q35234371-38ACE41D-316D-4B57-80FC-F66E345BE979 Q35374935-1C742D28-B5E9-42E8-90D8-0149323AB753 Q35684846-D16FA6BD-592D-4E0D-A101-0CF73D84AA48 Q35828049-4C840F2B-BD7A-474E-9512-B48F4A0BB799

P2860

Drug export activity of the human canalicular multispecific organic anion transporter in polarized kidney MDCK cells expressing cMOAT (MRP2) cDNA

http://www.wikidata.org/entity/Q24564700

description

1998 nî lūn-bûn

@nan

1998 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

1998 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

1998年の論文

@ja

1998年論文

@yue

1998年論文

@zh-hant

1998年論文

@zh-hk

1998年論文

@zh-mo

1998年論文

@zh-tw

1998年论文

@wuu

name

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@ast

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@en

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@nl

type

label

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@ast

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@en

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@nl

prefLabel

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@ast

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@en

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@nl

P1433

Q24564700-083CE212-A156-413F-972F-203982F03FBD

P1476

Q24564700-19E3A2D0-11F3-423E-8C9F-BE526C410D25

P2093

Q24564700-1180784B-15F2-49A3-928E-D567CADD80C8

Q24564700-21776FA7-9676-4B96-A602-7D30F7AA0F08

Q24564700-25C8F6C3-2891-4E5C-BB6C-8E3DBA9F1BC7

Q24564700-43D1DC0C-88C0-4DC5-8561-4D2A28ACC84C

Q24564700-6DC4FC2E-EA74-4A38-BB87-C4C8DF9B542D

Q24564700-789074CC-9C6C-4E09-B4F5-70EAB6DA0F47

Q24564700-7A00A145-30B0-403C-BA5B-8E0338A1FC96

Q24564700-BE859941-EA7A-4E15-B854-9C46BC692572

Q24564700-EC67B808-0D76-45BD-BF16-371A169ADC14

Q24564700-ED0D060F-98DE-40E0-BB91-790C86CE805C

P2860

Q24564700-07797673-95A1-4EFD-A78C-FB1C73814D87

Q24564700-07A4FAF4-E199-4D1E-8415-AD056A165A9A

Q24564700-1024EECF-49F3-4D64-A70D-87756A2CF8C5

Q24564700-1520FED7-4AC2-44B7-89C6-C2A58AEE3159

Q24564700-182FF3FC-A0D6-4CFB-B840-67D189906A79

Q24564700-1969369E-B021-44DF-8C66-AC92D30ED277

Q24564700-1A998379-DBF8-4B5F-95FC-1A21EC70E12A

Q24564700-224692C6-0794-4A30-BDE3-241B333DB86C

Q24564700-28DD60EB-EBD3-4002-8083-0A8A66BE69BF

Q24564700-28E42A97-BB57-46F1-BE11-EFFA1868DC07

P304

Q24564700-9AA0EA99-E687-40CB-83BA-5B5C1508B6D0

P31

Q24564700-EF9A9E02-4669-4BB3-91EE-502175B53B16

P356

Q24564700-6E118572-6190-49C9-873B-5791C2BE5D39

P407

Q24564700-85D3158D-1C5C-4AA6-9485-681644EB5F87

P433

Q24564700-5965C794-984A-49E4-9763-9ECF8C2E145B

P4510

Q24564700-4F36A3D5-682C-4E5E-A51F-640F4E0E0517

P478

Q24564700-4D52E534-CE12-47BC-9D3A-AE272F1DECE8

P50

Q24564700-D10AF4D7-DD9D-47BA-A2EF-F961A0F81D34

P577

Q24564700-145A096B-EFE1-4AB8-9A3B-0F511C7A3F7A

P698

Q24564700-BCC8AC3D-C3E5-4E71-A701-03E991B96CA6

P921

Q24564700-A6F39692-E89F-4DD1-808B-599571D5BB23

P932

Q24564700-C7C1D17F-D0E2-426E-ACDD-D87C8677AC51

P356

P1433

Journal of Clinical Investigation

P1476

Drug export activity of the hu ...... s expressing cMOAT (MRP2) cDNA

@en

P2093

A H Schinkel

http://www.w3.org/2001/XMLSchema#string

F Baas

http://www.w3.org/2001/XMLSchema#string

H Janssen

http://www.w3.org/2001/XMLSchema#string

J Calafat

http://www.w3.org/2001/XMLSchema#string

L C Oomen

http://www.w3.org/2001/XMLSchema#string

L van Deemter

http://www.w3.org/2001/XMLSchema#string

M Kool

http://www.w3.org/2001/XMLSchema#string

P Borst

http://www.w3.org/2001/XMLSchema#string

R Evers

http://www.w3.org/2001/XMLSchema#string

R P Oude Elferink

http://www.w3.org/2001/XMLSchema#string

P2860

Expression of the MRP gene-encoded conjugate export pump in liver and its selective absence from the canalicular membrane in transport-deficient mutant hepatocytes

Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line

ABC transporters: from microorganisms to man

Functional antagonism between c-Jun and MyoD proteins: a direct physical association

A mutation in the human canalicular multispecific organic anion transporter gene causes the Dubin-Johnson syndrome

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines

cDNA cloning of the hepatocyte canalicular isoform of the multidrug resistance protein, cMrp, reveals a novel conjugate export pump deficient in hyperbilirubinemic mutant rats

A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation

Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia

Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene

P304

1310-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI119886

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P4510

P478

101

http://www.w3.org/2001/XMLSchema#string

P50

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9525973

http://www.w3.org/2001/XMLSchema#string

P921

P932

508708

http://www.w3.org/2001/XMLSchema#string